REAL-TIME AI PLATFORM BEATS BIOPSY AT DIAGNOSING CANCER — UMASS STUDY IS A MEDICAL FIRST A landmark UMass trial called SMART-AI showed that a real-time AI platform outperformed traditional biopsy at diagnosing bile duct cancer, one of the hardest cancers to detect early. The implications are massive: biopsies are invasive, expensive, and often miss early-stage tumors, making AI-based diagnosis a potential replacement for the gold standard. Keywords: AI cancer diagnosis, SMART-AI trial, biopsy alternative, UMass medical AI